Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
life sciences
national blog main
5
×
boston
boston blog main
boston top stories
bristol-myers squibb
cancer
cancer immunotherapy
gene editing
national
national top stories
novartis
samit hirawat
allergan
brexanalone
clinical data
clinical study
clinical trials
crispr
cynthia collins
data
depression
disease
drugs
editas medicine
enzyme
gag
genome editing
hunter syndrome
ids
jeff jonas
katrine bosley
leber congenital amaurosis
major depressive disorder
mental illness
mps ii
mucopolysaccharidosis ii
neuroscience
phase 3 trial
What
trial
5
×
clinical
medical
acquisition
anniversary
approaches
bn
bristol
celgene
chief
company’s
corporation
diversity
editing
gene
hirawat
humans
medicine
myers
myers’s
officer
phase
pipeline
progress
scrip
spoke
squibb
therapeutics
year
allergan
approval
benefit
blessing
bosley
brexanalone
ceo
check
crispr
cusp
depart
Language
unset
Current search:
trial
×
photo
×
" national blog main "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
